The Cyprus Institute of Neurology and Genetics leads Pilot 8 of the COMFORTage project, which observes Alzheimer’s disease patients, people with mild cognitive impairment (MCI), and healthy individuals through a variety of molecular, clinical, neuropsychological, and movement tests which will be later combined and analysed via modern multi-modal data integration techniques. This pilot aims to improve the prediction of disease in Cypriot patients allowing timely prevention and identify dysphagia biomarkers to improve diagnosis and suggest early treatment, prior to malnutrition stages.
Title: Monitoring and follow-up of AD patients towards improved and personalized recommendations
Partner: CING
Type: Observational
Target: AD, MCI, and controls
Focus: Recruitment of AD, MCI patients and controls to be assessed by neurologist, neuropsychologist, physiotherapist, speech language pathologist, and by VFSS and MRI
Type of prevention targeted: Enable more accurate prediction of dementia in Cyprus through modern multi-modal data integration techniques of clinical and molecular tests and timely detection of dysphagia stages in diseased individuals to prevent malnutrition
Objective: Observation of changes in cognition over time by comparing healthy, mild cognitive impairment, and Alzheimer’s disease patients through a variety of clinical and molecular tests over time
Category: Category #C – Study of Improved and Personalized Interventions That May Delay and Alleviate Dementia
